iBio, Inc.
IBIO · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $8,012 | $7,700 | $14,945 | $113,373 |
| - Cash | $8,582 | $14,210 | $4,301 | $22,676 |
| + Debt | $3,508 | $4,460 | $17,074 | $25,766 |
| Enterprise Value | $2,938 | -$2,050 | $27,718 | $116,463 |
| Revenue | $400 | $225 | $0 | $1,884 |
| % Growth | 77.8% | – | -100% | – |
| Gross Profit | $400 | $225 | $0 | -$1,907 |
| % Margin | 100% | 100% | – | -101.2% |
| EBITDA | -$17,039 | -$14,021 | -$27,848 | -$25,722 |
| % Margin | -4,259.8% | -6,231.6% | – | -1,365.3% |
| Net Income | -$18,377 | -$24,907 | -$65,010 | -$50,391 |
| % Margin | -4,594.3% | -11,069.8% | – | -2,674.7% |
| EPS Diluted | -1.75 | -6.5 | -23.94 | -58.49 |
| % Growth | 73.1% | 72.8% | 59.1% | – |
| Operating Cash Flow | -$15,304 | -$18,554 | -$30,436 | -$37,802 |
| Capital Expenditures | -$16 | -$210 | -$5,738 | -$7,330 |
| Free Cash Flow | -$15,320 | -$18,764 | -$36,174 | -$45,132 |